You are here

  • Home
  • Archive
  • Volume 20, Issue 5
  • Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome

Authors

  1. Correspondence to : Dr Peter P Toth, Department of Preventive Cardiology, CGH Medical Center, 101 East Miller Rd, Sterling, IL 61081, USA; Peter.toth{at}cghmc.com
View Full Text

Citation

Toth PP
Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome
BMJ Evidence-Based Medicine 2015;20:176.

Publication history

  • First published August 10, 2015.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions